Loading...
| A03079 | Pages: 195 | Aug 2021 | 5802 Views | | |
| Author(s) : Sushant Terdale , Onkar Sumant | Tables: 121 | Charts: 26 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Implantable Insulin Pump Market
Request Now !The global implantable insulin pump market size was valued at $2,674 million in 2020, and is projected to reach $6,443 million by 2030, registering a CAGR of 9.1% from 2021 to 2030. Implanted insulin pump is a medical device that remains inside the human body at all times. This implanted insulin pump delivers insulin into the peritoneal cavity, which has more number of blood vessels and can hence absorb insulin very efficiently. Implantable insulin pumps provide better treatment solutions for people who suffer from diabetes disease. There are two types of implantable insulin pumps are available in market, which include closed-loop insulin pump and open-loop insulin pump.
Get more information on this report : Request Sample Pages
Rise in population suffering from diabetes along with increase in awareness about insulin treatments that are available in the implantable insulin pump market drives the growth of the market. Moreover, technological advancements in implantable insulin pumps, rise in incidences of chronic diseases such as obesity and heart disorder and surge in demand for home-based therapies for diabetes management and consultation propel the growth of the market. Furthermore, rise in geriatric population coupled with increase in prevalence of diabetes, supportive reimbursement policies in healthcare system, and rise in R&D activities toward the development of novel implantable insulin pump products further boost the growth of the market. However, stringent government regulations expected to hamper the market growth during the forecast period. Conversely, high growth potential in emerging markets is expected to offer lucrative opportunities during the forecast period.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The COVID-19 pandemic has disrupted virtually each aspect of healthcare provision, including diabetes care. The impact of this pandemic on the implantable insulin pump market will provide learnings to medical device companies across other therapy areas both in the short and the long term. However, the outbreak of COVID-19 is expected to contribute to the growth opportunities for industries wherein the treatment and management of chronic conditions are carried out. According to several statistics from around the global scientific community, it is observed that the complications caused due to coronavirus include diabetic ketoacidosis, pneumonia, dehydration, and high blood sugar. Therefore, the diabetic care segment was observed to proliferate due to COVID-19. Thus, the outbreak of COVID-19 positively impacted the growth of the global market.
The implantable insulin pump market is segmented on the basis of type, disease, end user, and region. On the basis of type, the market is categorized into closed-loop insulin pump and open-loop insulin pump.
By disease, the market is divided into type 1 diabetes and type 2 diabetes. On the basis of end user, the market is categorized into hospitals and home care. The hospitals segment is further segmented into type 1 diabetes and type 2 diabetes. The home care segment is further segmented into type 1 diabetes and type 2 diabetes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Get more information on this report : Request Sample Pages
On the basis of type, the open-loop insulin pump segment is the major revenue contributor, and is projected to grow significantly during the forecast period. Increase in demand for minimally invasive devices along with surge in incidences of diabetes among population are expected to drive the growth of the open-loop insulin pumps market. In addition, surge in awareness regarding advanced methods for insulin delivery through pumps, increase in investment in research and development (R&D) for open-loop insulin pumps are the major factors which boost the market growth of this segment.
By disease, the type 1 diabetes segment is the major shareholder in the implantable insulin pump market, owing to rise in prevalence of type 1 diabetes across the globe, increase in demand for implantable insulin pump, increase in number implantable insulin pump manufacturing companies, and surge in public awareness towards type 1 diabetes treatment methods.
Get more information on this report : Request Sample Pages
Asia-Pacific presents lucrative opportunities for key players operating in the implantable insulin pump market, owing to increase in number of initiatives and enhanced investments from governments for overall R&D of implantable insulin pump and rise in number of product approvals. In addition, ongoing innovations in implantable insulin pump, availability of advanced healthcare systems, and significant surge in demand for advanced healthcare facilities contribute toward growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the implantable insulin pump market in the region.
The key players profiled in this report include Apex Medical, CVS Health (Aetna Inc.), Diabeloop, Diamesco Co., Ltd, F. Hoffmann La Roche Ltd, Insulet Corporation, Johnson & Johnson, Medtronic Plc, SOOIL Developments Co. Ltd, and Tandem Diabetes Care.
Get more information on this report : Request Sample Pages
Key Benefits For Stakeholders
Key Market Segments
By Type
By Disease
By End User
By Region
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of diabetes worldwide
3.5.1.2.Sedentary and unhealthy lifestyle pattern
3.5.1.3.Increase in government expenditure on healthcare
3.5.2.Restraint
3.5.2.1.Stringent government regulations
3.5.3.Opportunities
3.5.3.1.High market growth potential in emerging markets
3.5.4.Impact analysis
3.6.Covid-19 Impact analysis on implantable insulin pump market
CHAPTER 4:IMPLANTABLE INSULIN PUMP MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Closed-loop insulin pump
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Open-loop insulin pump
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
CHAPTER 5:IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE
5.1.Overview
5.1.1.Market size and forecast
5.2.Type 1 diabetes
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Type 2 diabetes
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:IMPLANTABLE INSULIN PUMP MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.2.3.Market size and forecast, by disease
6.3.Home care
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.3.3.Market size and forecast, by disease
CHAPTER 7:IMPLANTABLE INSULIN PUMP MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
U.S. implantable insulin pump market, by type
U.S. implantable insulin pump market, by disease
U.S. implantable insulin pump market, by end user
7.2.2.2.Canada
Canada implantable insulin pump market, by type
Canada implantable insulin pump market, by disease
Canada implantable insulin pump market, by end user
7.2.2.3.Mexico
Mexico implantable insulin pump market, by type
Mexico implantable insulin pump market, by disease
Mexico implantable insulin pump market, by end user
7.2.3.North America market size and forecast, by type
7.2.4.North America market size and forecast, by disease
7.2.5.North America market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
Germany implantable insulin pump market, by type
Germany implantable insulin pump market, by disease
Germany implantable insulin pump market, by end user
7.3.2.2.France
France implantable insulin pump market, by type
France implantable insulin pump market, by disease
France implantable insulin pump market, by end user
7.3.2.3.UK
UK implantable insulin pump market, by type
UK implantable insulin pump market, by disease
UK implantable insulin pump market, by end user
7.3.2.4.Italy
Italy implantable insulin pump market, by type
Italy implantable insulin pump market, by disease
Italy implantable insulin pump market, by end user
7.3.2.5.Spain
Spain implantable insulin pump market, by type
Spain implantable insulin pump market, by disease
Spain implantable insulin pump market, by end user
7.3.2.6.Rest of Europe
Rest of Europe implantable insulin pump market, by type
Rest of Europe implantable insulin pump market, by disease
Rest of Europe implantable insulin pump market, by end user
7.3.3.Europe market size and forecast, by type
7.3.4.Europe market size and forecast, by disease
7.3.5.Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
Japan implantable insulin pump market, by type
Japan implantable insulin pump market, by disease
Japan implantable insulin pump market, by end user
7.4.2.2.China
China implantable insulin pump market, by type
China implantable insulin pump market, by disease
China implantable insulin pump market, by end user
7.4.2.3.Australia
Australia implantable insulin pump market, by type
Australia implantable insulin pump market, by disease
Australia implantable insulin pump market, by end user
7.4.2.4.India
India implantable insulin pump market, by type
India implantable insulin pump market, by disease
India implantable insulin pump market, by end user
7.4.2.5.South Korea
South Korea implantable insulin pump market, by type
South Korea implantable insulin pump market, by disease
South Korea implantable insulin pump market, by end user
7.4.2.6.Rest of Asia-Pacific
Rest of Asia-Pacific implantable insulin pump market, by type
Rest of Asia-Pacific implantable insulin pump market, by disease
Rest of Asia-Pacific implantable insulin pump market, by end user
7.4.3.Asia-Pacific market size and forecast, by type
7.4.4.Asia-Pacific market size and forecast, by disease
7.4.5.Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
Brazil implantable insulin pump market, by type
Brazil implantable insulin pump market, by disease
Brazil implantable insulin pump market, by end user
7.5.2.2.Saudi Arabia
Saudi Arabia implantable insulin pump market, by type
Saudi Arabia implantable insulin pump market, by disease
Saudi Arabia implantable insulin pump market, by end user
7.5.2.3.South Africa
South Africa implantable insulin pump market, by type
South Africa implantable insulin pump market, by disease
South Africa implantable insulin pump market, by end user
7.5.2.4.Rest of LAMEA
Rest of LAMEA implantable insulin pump market, by type
Rest of LAMEA implantable insulin pump market, by disease
Rest of LAMEA implantable insulin pump market, by end user
7.5.3.LAMEA market size and forecast, by type
7.5.4.LAMEA market size and forecast, by disease
7.5.5.LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.Apex Medical
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.2.CVS Health (Aetna Inc.)
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.3.Diabeloop SACA
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments
8.4.DIAMESCO CO., LTD.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.F. Hoffmann La Roche Ltd.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.Insulet Corporation
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.Johnson & Johnson
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.Medtronic PLC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.Sooil Developments Co. Ltd.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments
8.10.Tandem Diabetes Care Inc.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.CLOSED-LOOP INSULIN PUMP MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.CHIMERIC IMPLANTABLE INSULIN PUMP MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04.IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 05.IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 1 DIABETES, BY REGION, 2020-2030 ($MILLION)
TABLE 06.IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 2 DIABETES, BY REGION, 2020-2030 ($MILLION)
TABLE 07.IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 08.IMPLANTABLE INSULIN PUMP MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
TABLE 09.IMPLANTABLE INSULIN PUMP MARKET FOR HOSPITALS, BY DISEASE, 2020–2030 ($MILLION)
TABLE 10.IMPLANTABLE INSULIN PUMP MARKET FOR HOME CARE, BY REGION, 2020-2030 ($MILLION)
TABLE 11.IMPLANTABLE INSULIN PUMP MARKET FOR HOME CARE, BY DISEASE, 2020–2030 ($MILLION)
TABLE 12.IMPLANTABLE INSULIN PUMP MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 13.NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 14.U.S. IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 15.U.S. IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 16.U.S. IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 17.CANADA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 18.CANADA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 19.CANADA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 20.MEXICO IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 21.MEXICO IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 22.MEXICO IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 23.NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 24.NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 25.NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 26.EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 27.GERMANY IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 28.GERMANY IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 29.GERMANY IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 30.FRANCE IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 31.FRANCE IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 32.FRANCE IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 33.UK IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 34.UK IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 35.UK IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36.ITALY IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 37.ITALY IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 38.ITALY IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39.SPAIN IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 40.SPAIN IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 41.SPAIN IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 42.REST OF EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 43.REST OF EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 44.REST OF EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45.EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 46.EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 47.EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 48.ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 49.JAPAN IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 50.JAPAN IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 51.JAPAN IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 52.CHINA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 53.CHINA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 54.CHINA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 55.AUSTRALIA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 56.AUSTRALIA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 57.AUSTRALIA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 58.INDIA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 59.INDIA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 60.INDIA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61.SOUTH KOREA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 62.SOUTH KOREA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 63.SOUTH KOREA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64.REST OF ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 65.REST OF ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 67.ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 68.ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 69.ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70.LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 71.BRAZIL IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 72.BRAZIL IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 73.BRAZIL IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 74.SAUDI ARABIA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 75.SAUDI ARABIA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 76.SAUDI ARABIA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 77.SOUTH AFRICA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 78.SOUTH AFRICA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 79.SOUTH AFRICA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 80.REST OF LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 81.REST OF LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 82.REST OF LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 83.LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 84.LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020–2030 ($MILLION)
TABLE 85.LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86.APEX MEDICAL: COMPANY SNAPSHOT
TABLE 87.APEX MEDICAL: OPERATING SEGMENTS
TABLE 88.APEX MEDICAL: PRODUCT PORTFOLIO
TABLE 89.CVS HEALTH (ATENA INC).: COMPANY SNAPSHOT
TABLE 90.CVS HEALTH (AETNA INC).: OPERATING SEGMENTS
TABLE 91.CVS HEALTH (AETNA INC.): PRODUCT PORTFOLIO
TABLE 92.DIABELOOP SACA: COMPANY SNAPSHOT
TABLE 93.DIABELOOP SACA: OPERATING SEGMENTS
TABLE 94.DIABELOOP SACA: PRODUCT PORTFOLIO
TABLE 95.DIABELOOP SACA.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96.DIAMESCO: COMPANY SNAPSHOT
TABLE 97.DIAMESCO: OPERATING SEGMENTS
TABLE 98.DIAMESCO: PRODUCT PORTFOLIO
TABLE 99.F. HOFFMANN LA ROCHE LTD: COMPANY SNAPSHOT
TABLE 100.F. HOFFMANN LA ROCHE LTD: OPERATING SEGMENTS
TABLE 101.F. HOFFMANN LA ROCHE LTD: PRODUCT PORTFOLIO
TABLE 102.F. HOFFMANN LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103.INSULET CORPORATION: COMPANY SNAPSHOT
TABLE 104.INSULET CORPORATION: OPERATING SEGMENTS
TABLE 105.INSULET CORPORATION: PRODUCT PORTFOLIO
TABLE 106.INSULET CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 108.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 109.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 110.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 111.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 112.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 113.MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114.SOOIL DEVELOPMENTS CO. LTD.: COMPANY SNAPSHOT
TABLE 115.SOOIL DEVELOPMENTS CO. LTD.: OPERATING SEGMENTS
TABLE 116.SOOIL DEVELOPMENTS CO. LTD.: PRODUCT PORTFOLIO
TABLE 117.SOOIL DEVELOPMENTS CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 118.TANDEM DIABETES CARE INC.: COMPANY SNAPSHOT
TABLE 119.TANDEM DIABETES CARE INC.: OPERATING SEGMENTS
TABLE 120.TANDEM DIABETES CARE INC: PRODUCT PORTFOLIO
TABLE 121.TANDEM DIABETES CARE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.IMPLANTABLE INSULIN PUMP MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 01.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 02.MODERATE BARGAINING POWER OF BUYERS
FIGURE 03.MODERATE THREAT OF SUBSTITUTES
FIGURE 04.LOW THREAT OF NEW ENTRANTS
FIGURE 05.HIGH INTENSITY OF RIVALRY
FIGURE 06.TOP PLAYER POSITIONING, 2020
FIGURE 07.IMPACT ANALYSIS
FIGURE 08.COMPARATIVE ANALYSIS OF CLOSED-LOOP INSULIN PUMP MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 09.COMPARATIVE ANALYSIS OF CHIMERIC IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 10.COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 11.COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 12.COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR HOME CARE, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.CVS HEALTH (ATENA INC).: NET SALES, 2018–2020 ($MILLION)
FIGURE 15.F. HOFFMANN LA ROCHE LTD: NET SALES, 2018-2020 ($MILLION)
FIGURE 16.INSULET CORPORATION: NET SALES, 2017–2019 ($MILLION)
FIGURE 17.INSULET CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 18.INSULET CORPORATION: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 19.JOHNSON & JOHNSON: NET SALES, 2018–2020 ($MILLION)
FIGURE 20.JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 21.JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 22.MEDTRONIC PLC: NET SALES, 2018–2020 ($MILLION)
FIGURE 23.MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 24.MEDTRONIC PLC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 25.TANDEM DIABETES CARE INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.TANDEM DIABETES CARE INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
Implanted insulin pumps (IIPs) are an alternative treatment option for diabetes mellitus disease. These pumps maintain good glycemic control that require frequent surgical interventions.
Implanted insulin pumps helps to improve the adherence to medication, thus providing better diabetes management. Advancements in implanted insulin pumps along with improved effectiveness and usability is expected to help increase the adoption rate of these products, which would largely contribute toward the market growth. Furthermore, rise in disposable income, favorable reimbursement policies, and increase in healthcare expenditure, is also anticipated to boost the market growth. Moreover, advancements in digital applications for monitoring blood glucose level with the help of augmented & virtual reality for diabetes management further drives the growth of the market.
A. The total market value of Implantable Insulin Pump market is $2,673.5 million in 2020.
A. The forcast period for Implantable Insulin Pump market is 2021 to 2030
A. The market value of Implantable Insulin Pump market in 2021 is $2,930.2 million.
A. The base year is 2020 in Implantable Insulin Pump market
A. Top companies such as F. Hoffmann La Roche Ltd, Johnson & Johnson, Medtronic Plc, Tandem Diabetes Care, Apex Medical, CVS Health (Aetna Inc.), and Diabeloop held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Open-loop insulin pumps segment is the most influencing segment owing to increase in demand for minimally invasive devices along with surge in incidences of diabetes among population are expected to drive the growth of the open-loop insulin pumps market. In addition, surge in awareness regarding advanced methods for insulin delivery through pumps, increase in investment in research and development (R&D) for open-loop insulin pumps are the major factors which boost the market growth of this segment.
A. Rise in population suffering from diabetes along with increase in awareness about insulin treatments that are available in the market drives the growth of the market. Moreover, technological advancements in implantable insulin pumps, rise in incidences of chronic diseases such as obesity and heart disorder and surge in demand for home-based therapies for diabetes management and consultation propel the growth of the market.
A. Asia-Pacific has the highest growth rate in the market which is growing due to increase in number of initiatives and enhanced investments from governments for overall R&D of implantable insulin pump and rise in number of product approvals. In addition, ongoing innovations in implantable insulin pump, availability of advanced healthcare systems, and significant surge in demand for advanced healthcare facilities contribute toward growth of the market.
A. Implantable insulin pump is a medical device which helps in delivering insulin into peritoneal cavity, and remains inside the human body all the time.
A. The implantable insulin pumps are projected to revolutionize the treatment of diabetes disease and also gives a constructive solution for accurately effective artificial pancreas.
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
